Stay updated on Gantenerumab in Mild Alzheimer Disease Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab in Mild Alzheimer Disease Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changed from v3.8.0 to v3.8.1, with no change to the study record content.
    Difference
    0.0%
    Check dated 2026-11-18T02:25:42.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The completed Phase 3 study of gantenerumab for mild Alzheimer disease is now displayed, with its study design, eligibility criteria, outcomes, locations, and record documents.
    Difference
    100%
    Check dated 2026-11-11T01:33:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:51:34.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision label also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:54:14.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:09:38.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error screen with a minimal header and a Home link, replacing the full study record content that was previously visible. This indicates restricted access to the page.
    Difference
    18%
    Check dated 2026-09-22T23:57:53.000Z thumbnail image

Stay in the know with updates to Gantenerumab in Mild Alzheimer Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.